Advanced pancreatic adenocarcinoma outcomes with transition from devolved to centralised care in a regional Cancer Centre.

about

Advanced pancreatic adenocarcinoma outcomes with transition from devolved to centralised care in a regional Cancer Centre.

Item

http://www.wikidata.org/entity/Q39024255

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Advanced pancreatic adenocarci ...... e in a regional Cancer Centre.

@en

Advanced pancreatic adenocarci ...... e in a regional Cancer Centre.

@nl

type

Item

label

Advanced pancreatic adenocarci ...... e in a regional Cancer Centre.

@en

Advanced pancreatic adenocarci ...... e in a regional Cancer Centre.

@nl

prefLabel

Advanced pancreatic adenocarci ...... e in a regional Cancer Centre.

@en

Advanced pancreatic adenocarci ...... e in a regional Cancer Centre.

@nl

P1476

Advanced pancreatic adenocarci ...... e in a regional Cancer Centre.

@en

P2093

Carl Ikin

http://www.w3.org/2001/XMLSchema#string

Daniel H Palmer

http://www.w3.org/2001/XMLSchema#string

Helen Wong

http://www.w3.org/2001/XMLSchema#string

Joanna L Connor

http://www.w3.org/2001/XMLSchema#string

Madhuchanda Chatterjee

http://www.w3.org/2001/XMLSchema#string

Olusola O Faluyi

http://www.w3.org/2001/XMLSchema#string

P2860

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database.

Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase III-study from the German CONKO-study group.

Strengthening clinical cancer research in the United Kingdom.

Pancreatic cancer within a UK cancer network with special emphasis on locally advanced non-metastatic pancreatic cancer.

Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer.

Evidence for treatment and survival disparities by age in pancreatic adenocarcinoma: a population-based analysis.

Pancreatic cancer: from state-of-the-art treatments to promising novel therapies.

P2888

bjc.2016.406

P304

424-431

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2016.406

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28081546

http://www.w3.org/2001/XMLSchema#string

P932

5318965

http://www.w3.org/2001/XMLSchema#string